Early gastrointestinal neoplasia
Conditions
Interventions
Group 1: This is a multicentre registry study collecting data generated in the course of routine clinical care. No control group is planned. Randomisation and blinding are not planned.
During the stud
Sponsors
Universitätsklinikum Augsburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Therapy decision for ESD/EID for gastrointestinal neoplasia ability for informed consent given informed consent
Exclusion criteria
Exclusion criteria: decision against inclusion into the study inability to give informed consent (also because of a language barrier) age < 18 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Aim of the study: Evaluation of the long term follow up after endoscopic submucosal dissection and endoscopic intermuscular dissection Primary endpoint: Overall survival (1, 3 and 5 years after inclusion in the study) measured by telefonic evaluation of the health status | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary aims of the study: Evaluation of the current standard of endoscopic submucosal dissection and endoscopic intermuscular dissection in a real-world setting Secondary endpoints: disease-specific survival, recurrence rates, complication rates, characterstics of the resection, histopathologic results; all measured by data extraction from the medical record | — |
Countries
Germany
Contacts
Public ContactMarkus Scheppach
Universitätsklinikum Augsburg
Outcome results
None listed